SCHEMBL822357

SCHEMBL822357

C=CCc1cc(CC=C)c(O)c(C(c2cc(CC=C)cc(CC=C)c2O)c2cc(CC=C)cc(CC=C)c2O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 2/20 0.40
XDH P47989 2/20 0.40
PARP1 P09874 1/20 0.40
MGAM O43451 2/20 0.40
GABRA1 P14867 7/20 0.39
GABRB2 P47870 7/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
CNR1 P21554 2/20 0.39
CNR2 P34972 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALDH2 P05091 1/20 0.39
AKR1B1 P15121 1/20 0.39
HPGD P15428 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2461750 0.84 XDH (0.48) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL9285307 0.79 XDH (0.41) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL11660795 0.79 DHFR (0.46) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL9319191 0.79 TNKS (0.56) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL9285299 0.77 XDH (0.42) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL11261537 0.77 XDH (0.42) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL9703377 0.76 XDH (0.41) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL18657227 0.76 GABRA1 (0.52) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL27771899 0.76 SHBG (0.48) TNKSXDHPARP1GABRA1GABRB2
SCHEMBL9284341 0.75 DHFR (0.43) XDHGABRA1GABRB2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9428432-B2 Derivatives of tris(2-hydroxyphenyl)methanes, preparation thereof and use thereof for mineral oil production BASF Wintershall Holding GmbH (DE) 2016-08-30 US disclosed
EP-2782666-B1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION Wintershall Holding GmbH (DE) 2016-02-03 EP disclosed
US-9212545-B2 Use of tris(2-hydroxyphenyl)methane derivatives for tertiary mineral oil production Wintershall Holding GmbH (DE) 2015-12-15 US disclosed
EP-2571923-B1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF BASF SE (DE) 2014-12-17 EP disclosed
EP-2782666-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION Wintershall Holding GmbH (DE) 2014-10-01 EP disclosed
EP-2768924-A1 USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY PETROLEUM PRODUCTION Wintershall Holding GmbH (DE) 2014-08-27 EP disclosed
US-8618321-B2 Derivatives of tris(2-hydroxyphenyl)methane, their preparation and use BASF SE (DE) 2013-12-31 US disclosed
US-20130228332-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, PREPARATION THEREOF AND USE THEREOF FOR MINERAL OIL PRODUCTION BASF Wintershall Holding GmbH 2013-09-05 US disclosed
WO-2013076006-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, THE PRODUCTION THEREOF AND USE THEREOF FOR OIL PRODUCTION Wintershall Holding GmbH (DE) 2013-05-30 WO disclosed
US-20130098609-A1 USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY MINERAL OIL PRODUCTION Wintershall Holding GmbH (DE) 2013-04-25 US disclosed
WO-2013057044-A1 USE OF TRIS(2-HYDROXYPHENYL)METHANE DERIVATIVES FOR TERTIARY PETROLEUM PRODUCTION Wintershall Holding GmbH (DE) 2013-04-25 WO disclosed
EP-2571923-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF BASF SE (DE) 2013-03-27 EP disclosed
WO-2011144643-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, AND PREPARATION AND USE THEREOF BASF SE (DE) 2011-11-24 WO disclosed
US-20110288322-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, THEIR PREPARATION AND USE BASF SE (DE) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288322-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANE, THEIR PREPARATION AND USE MGMT, HPGDS, TOP2A TNKS 673/4885XDH 2339/4885PARP1 2743/4885
US-20130228332-A1 DERIVATIVES OF TRIS(2-HYDROXYPHENYL)METHANES, PREPARATION THEREOF AND USE THEREOF FOR MINERAL OIL PRODUCTION HPGDS, SQLE, HSD17B4 TNKS 1767/4885XDH 1854/4885PARP1 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.